Lupus Erythematosus News and Research

RSS
Lupus Research Alliance announces recipients of the 2022 Distinguished Innovator Award focused on studying T cells in lupus

Lupus Research Alliance announces recipients of the 2022 Distinguished Innovator Award focused on studying T cells in lupus

CAR T therapy extends its reach beyond oncology

CAR T therapy extends its reach beyond oncology

PALS program effective in ensuring diverse representation in lupus clinical trials

PALS program effective in ensuring diverse representation in lupus clinical trials

Oral deucravacitinib shows promise in patients with active lupus

Oral deucravacitinib shows promise in patients with active lupus

First placebo-controlled long-term trial of anifrolumab shows positive results in patients with lupus

First placebo-controlled long-term trial of anifrolumab shows positive results in patients with lupus

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

Lower hydroxychloroquine dosing results in increased SLE-related hospitalizations, study finds

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

Shared genetic effects between the autoimmune disease systemic lupus erythematosus and the clinical consequences of COVID-19

Dietary components do not have impact on RMD outcomes

Dietary components do not have impact on RMD outcomes

The Black Death may have influenced the evolution of genes involved in immune responses against pathogens

The Black Death may have influenced the evolution of genes involved in immune responses against pathogens

Overview of the roles of neutrophils in systemic autoimmune and autoinflammatory diseases

Overview of the roles of neutrophils in systemic autoimmune and autoinflammatory diseases

Scientists receive $8.297 NIH grant to continue funding a Center for Lupus Research

Scientists receive $8.297 NIH grant to continue funding a Center for Lupus Research

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

Study reviews hydroxychloroquine and remdesivir antiviral potency against SARS‐CoV‐2

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Researchers explore single-cell sequencing technologies to understand molecular mechanisms of autoimmune diseases

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Could COVID-19 infections trigger a relapse of mycosis fungoides or other cutaneous T-cell lymphomas?

Immune-mediated inflammatory diseases following COVID-19

Immune-mediated inflammatory diseases following COVID-19

Review on COVID-19 biomedical waste-derived microplastic toxicity

Review on COVID-19 biomedical waste-derived microplastic toxicity

Study establishes a feasible combination therapeutic strategy for ulcerative colitis

Study establishes a feasible combination therapeutic strategy for ulcerative colitis

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Study explores the effect of age-associated B cells on COVID-19 vaccine-induced immunity

Patients with autoimmune diseases at greater risk of complications after heart attack

Patients with autoimmune diseases at greater risk of complications after heart attack

New data analysis approach could help uncover the genetic basis of many diseases

New data analysis approach could help uncover the genetic basis of many diseases

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.